2019 ESMO World GI Congress Highlights
July 17, 2019
Gastrointestinal cancers are the cause of approximately 40% of cancer deaths worldwide. The ESMO World Congress on Gastrointestinal Cancers (World GI) brings together a global community of clinicians, researchers, biopharmaceutical developers, and other experts to evaluate the latest innovations and future directions for tackling the unmet needs. We summarize below some of the key highlights including major advances in biomarker-directed targeted therapy, continued progress for immunotherapy, and continued optimization of chemotherapy.
Click HERE to read the full perspectives for the 2019 ESMO World GI Congress